WAT vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 17, 2026

WAT

46.2
AI Score
VS
XRAY Wins

XRAY

67.1
AI Score

Investment Advisor Scores

WAT

46score
Recommendation
HOLD

XRAY

67score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric WAT XRAY Winner
Forward P/E 24.7525 6.3291 XRAY
PEG Ratio 1.5658 0.633 XRAY
Revenue Growth 113.4% -4.1% WAT
Earnings Growth -3.1% 15.2% XRAY
Tradestie Score 46.2/100 67.1/100 XRAY
Profit Margin 3.6% -15.0% WAT
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

WAT 1M: +7.5% · 3M: +19.6% XRAY 1M: -8.7% · 3M: -28.6%

Current Technical Phase

WAT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.3% over 20 days), RSI 66

RSI (14): 65.9 · Price: $457.47

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.3 · Price: $9.08

Fundamentals Snapshot

Metric WAT XRAY
Market Cap — —
Forward P/E 27.7 6.1
Trailing P/E 112.1 —
Revenue (TTM) — —
Revenue Growth 1.1% 0.0%
Gross Margin 0.6% 0.5%
Operating Margin 0.1% 0.1%
EPS 3.95 -2.73
Dividend Yield — 0.04%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.